ACSH staffers would like to offer a seat at the table to Ken Green of the American Enterprise Institute for his article on the BPA scare.
He notes: "The safety of BPA has been affirmed by research undertaken by the U.S. National Toxicology Program, the U.S. Food and Drug Administration; the U.S. Centers for Disease Control; the European Food Safety Authority; Japan's National Institute of Advanced Industrial Science and Technology; Germany's Federal Environmental Agency; the European Commission's Scientific Committee on Toxicity, Ecotoxicity, and the Environment; the European Commission's Scientific Committee on Food; and the European Food Safety Authority."
"That's an important point," says ACSH's Dr. Elizabeth Whelan. "It leaves us with the same question we've been asking for a while: what is the FDA waiting for? BPA is safe at the levels we're exposed to. Anyone who knows anything about science knows that's the case."
"He also points out that the high-dose animal studies are not particularly relevant to humans, and that the so-called 'low-dose effect' invoked by the anti-BPA crowd to explain the lack of high-dose effects has been thoroughly discredited," adds ACSH's Dr. Gilbert Ross. "There is no scientific basis for attacks on BPA based on either 'endocrine disruption' or the 'low-dose effect'."